124 related articles for article (PubMed ID: 31449595)
21. A rare connection: fasciculoventricular pathway in PRKAG2 disease.
Govindan M; Ward D; Behr E
J Cardiovasc Electrophysiol; 2010 Mar; 21(3):329-32. PubMed ID: 19732236
[TBL] [Abstract][Full Text] [Related]
22. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
[TBL] [Abstract][Full Text] [Related]
23. Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutation.
Austin SL; Chiou A; Sun B; Case LE; Govendrageloo K; Hansen P; Kishnani PS
Mol Genet Metab; 2017; 120(1-2):96-100. PubMed ID: 27692944
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
[TBL] [Abstract][Full Text] [Related]
25. A Case Series on Cardiac and Skeletal Involvement in Two Families with PRKAG2 Mutations.
Sri A; Daubeney P; Prasad S; Baksi J; Kinali M; Voges I
Case Rep Pediatr; 2019; 2019():7640140. PubMed ID: 31049239
[TBL] [Abstract][Full Text] [Related]
26. [A familial form of conduction defects associated with a PRKAG2 gene mutation].
Pochmalicki G; Genest M; Richard P; Komajda M; Charron P
Arch Mal Coeur Vaiss; 2007 Sep; 100(9):760-5. PubMed ID: 18033003
[TBL] [Abstract][Full Text] [Related]
27. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S
Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862
[TBL] [Abstract][Full Text] [Related]
28. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
Miyamoto L
J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
[TBL] [Abstract][Full Text] [Related]
29. Wolff-Parkinson-White Syndrome with Ventricular Hypertrophy in a Brazilian Family.
van der Steld LP; Campuzano O; Pérez-Serra A; Moura de Barros Zamorano M; Sousa Matos S; Brugada R
Am J Case Rep; 2017 Jul; 18():766-776. PubMed ID: 28690312
[TBL] [Abstract][Full Text] [Related]
30. A familial form of conduction defect related to a mutation in the PRKAG2 gene.
Charron P; Genest M; Richard P; Komajda M; Pochmalicki G
Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151
[TBL] [Abstract][Full Text] [Related]
31. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.
Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; O'Sullivan J; Rowe G; Wakimoto H; Gorham J; Burke MA; Zhang K; Musunuru K; Gerszten RE; Wu SM; Chen CS; Seidman JG; Seidman CE
Cell Rep; 2016 Dec; 17(12):3292-3304. PubMed ID: 28009297
[TBL] [Abstract][Full Text] [Related]
32. Case report: Genomic screening for inherited cardiac conditions in Ecuadorian mestizo relatives: Improving familial diagnose.
Cadena-Ullauri S; Guevara-Ramirez P; Ruiz-Pozo V; Tamayo-Trujillo R; Paz-Cruz E; Sánchez Insuasty T; Doménech N; Ibarra-Rodríguez AA; Zambrano AK
Front Cardiovasc Med; 2022; 9():1037370. PubMed ID: 36426223
[TBL] [Abstract][Full Text] [Related]
33. Cardiac manifestations of PRKAG2 mutation.
Banankhah P; Fishbein GA; Dota A; Ardehali R
BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
[TBL] [Abstract][Full Text] [Related]
34. PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosis.
Aggarwal V; Dobrolet N; Fishberger S; Zablah J; Jayakar P; Ammous Z
Ann Pediatr Cardiol; 2015; 8(2):153-6. PubMed ID: 26085771
[TBL] [Abstract][Full Text] [Related]
35. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
Oliveira SM; Ehtisham J; Redwood CS; Ostman-Smith I; Blair EM; Watkins H
J Mol Cell Cardiol; 2003 Oct; 35(10):1251-5. PubMed ID: 14519435
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36.
Lang T; Yu L; Tu Q; Jiang J; Chen Z; Xin Y; Liu G; Zhao S
Genomics; 2000 Dec; 70(2):258-63. PubMed ID: 11112354
[TBL] [Abstract][Full Text] [Related]
38. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T
Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960
[TBL] [Abstract][Full Text] [Related]
39. Atrial Lesions in a Pedigree With
Chen S; Lin Y; Zhu Y; Geng L; Cui C; Li Z; Liu H; Chen H; Ju W; Chen M
Front Cardiovasc Med; 2022; 9():840337. PubMed ID: 35360035
[TBL] [Abstract][Full Text] [Related]
40. Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction?
Light PE
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S158-S161. PubMed ID: 16686673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
